Trial site
Manassas Clinical Research Center
- 11running trials
- 23closed trials
The trials here
What the 35 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes14 trials
- Obesity9 trials
- High blood pressure5 trials
- Fatty liver disease (MASLD/MASH)4 trials
- Familial hypercholesterolaemia3 trials
- Chronic kidney disease2 trials
- Diabetic neuropathy2 trials
- Gastroparesis2 trials
- Coronary artery disease1 trial
- Liver cirrhosis1 trial
- Stroke1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 221 trials
- Phase 314 trials
- Status
- Completed23 trials
- Recruiting6 trials
- Active, not recruiting5 trials
- Suspended1 trial
- Lead sponsor
- Hoffmann-La Roche5 trials
- Novartis Pharmaceuticals5 trials
- Ionis Pharmaceuticals, Inc.4 trials
- Biomea Fusion Inc.2 trials
- Boehringer Ingelheim2 trials
- and 13 more
Running trials
Recruiting
Recruiting
Recruiting
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
Active, not recruiting
A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity
Recruiting
An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Type 2 diabetes4 recruiting
- High blood pressure2 recruiting
- Obesity2 recruiting
- Familial hypercholesterolaemia1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia
Completed
Completed
A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of ION224
Completed
Completed
Study to Assess Safety and Efficacy of Engensis in Painful Diabetic Peripheral Neuropathy
Completed
Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)
Site data: ClinicalTrials.govUpdated 17 Nov 2026